TABLE 5.
Aloe vera whole-leaf extract (%)b | |||||
---|---|---|---|---|---|
Lesion | Sex | 0 | 1.0 | 2.0 | 3.0 |
Asending colon goblet cell hyperplasia | Male | 2/47 (4%)***1.0 | 16/44 (36%)***1.3 | 20/45 (44%)***1.6 | 19/42 (45%)***1.6 |
Female | 1/43 (2%)***1.0 | 15/43 (35%)***1.2 | 20/44 (46%)***1.3 | 25/43 (58%)***1.7 | |
Tranvserse colon goblet cell hyperplasia | Male | 4/47 (9%)***1.0 | 14/44 (32%)***1.4 | 21/45 (47%)***1.7 | 22/43 (51%)***1.6 |
Female | 2/42 (5%)***1.0 | 18/42 (43%)***1.2 | 23/44 (52%)***1.3 | 26/43 (61%)**1.7 | |
Decending colon goblet cell hyperplasia | Male | 0/47 (0%)***— | 7/44 (16%)**1.3 | 12/45 (27%)***1.5 | 17/43 (40%)***1.4 |
Female | 0/43 (0%)***— | 4/43 (9%)1.3 | 7/44 (16%)**1.4 | 17/43 (40%)***1.6 | |
Large intestine all sites goblet cell hyperplasiac | Male | 4/47 (9%)***1.0 | 17/44 (39%)***1.4 | 22/45 (49%)***1.9 | 22/44 (50%)1.7 |
Female | 3/43 (7%)***1.0 | 19/43 (44%)***1.2 | 24/44 (55%)***1.3 | 28/43 (65%)***1.7 | |
Mesenteric lymph node cellular infiltration | Male | 0/48 (0%)**— | 1/45 (2%)3.0 | 4/45 (9%)2.3 | 6/43 (14%)*3.2 |
Nose hyaline droplets | Male | 6/48 (13%)*1.2 | 31/47 (66%)***1.8 | 39/47 (83%)***2.0 | 13/47 (28%)1.8 |
aThe data are reported as the number of animals with a lesion per number of animals examined microscopically, the % incidence (in parentheses), and the mean severity of the lesion, where 1 = minimal, 2 = mild, 3 = moderate, 4 = marked.
b p values that are significant are annotated with * to indicate p < 0.05, ** to indicate p <0.01, or *** to indicate p < 0.001. p values associated with the 0% Aloe vera whole-leaf incidence correspond to Poly-3 trend tests. p values associated with a specific treatment correspond to differences compared to the 0% Aloe vera whole-leaf incidence.
cTotal number of mice with goblet cell hyperplasia in the ascending colon, transverse colon, or descending colon.